Page last updated: 2024-10-16

beta-alanine and Fatty Liver

beta-alanine has been researched along with Fatty Liver in 1 studies

Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.

Research Excerpts

ExcerptRelevanceReference
"Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of obesity and metabolic syndrome."5.40Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice. ( Flick, MJ; Joshi, N; Kassel, KM; Kopec, AK; Luyendyk, JP; Sullivan, BP; Towery, KL, 2014)
"Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of obesity and metabolic syndrome."1.40Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice. ( Flick, MJ; Joshi, N; Kassel, KM; Kopec, AK; Luyendyk, JP; Sullivan, BP; Towery, KL, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kopec, AK1
Joshi, N1
Towery, KL1
Kassel, KM1
Sullivan, BP1
Flick, MJ1
Luyendyk, JP1

Other Studies

1 other study available for beta-alanine and Fatty Liver

ArticleYear
Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice.
    The Journal of pharmacology and experimental therapeutics, 2014, Volume: 351, Issue:2

    Topics: Alanine Transaminase; Animals; Benzimidazoles; beta-Alanine; Bile Acids and Salts; Dabigatran; Diet,

2014